In addition, the higher expression levels of the ERCC1 gene have been linked with poor response of FOLFOX-based chemoradiation in colorectal cancer [48] and with the aggressiveness of esophageal cancer [49]. The gene discussed is ERCC1; the disease is esophageal cancer.